Analyst flags two healthcare stocks as buys amid sector optimism

Shrikant Chouhan, an analyst with Kotak Neo, has recommended two healthcare companies as attractive investment opportunities for investors seeking exposure to India's growing pharmaceutical and diagnostics sectors.

Chouhan's positive outlook on Mankind Pharma and Dr Lal Pathlabs reflects broader confidence in domestic healthcare companies as they benefit from expanding healthcare access across India and increasing demand for diagnostic services.

Manking Pharma, one of India's leading pharmaceutical manufacturers, has established itself across multiple therapeutic segments with a strong presence in both branded generics and over-the-counter medications. Dr Lal Pathlabs, meanwhile, operates as a major player in India's diagnostic services industry, serving patients across numerous cities through its network of pathology centers.

The bullish recommendation comes as healthcare stocks have attracted renewed investor attention amid the sector's resilience and growth potential in a developing economy. Analysts continue to monitor both companies' operational performance, market expansion plans, and ability to capitalize on India's growing healthcare spending.

Investors considering healthcare exposure may view such analyst recommendations as part of their broader due diligence process, alongside assessments of valuations, financial health, and sector dynamics.